This story originally ran on Nov. 11.

By Tony Fong

Discovering protein biomarkers and having them adopted by clinical practitioners are two distinct processes with different criteria.

If clinical proteomics will ever achieve success, proteomics researchers will need to master both processes. That was the take-home from some speakers at a meeting held last week by the American Association of Clinical Chemistry.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.